Company · CIK 0001694665 · SIC 2834 — Pharmaceutical Preparations
Evelo Biosciences, Inc. · EVLO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2018 CForm 4 → | May 21, 4:48 pm EDT | Alexandria Venture Investments, LLC10% Owner | 594,443 | — | — | 594,443 | — | plan? late |
| May 11, 2018 PForm 4 → | May 15, 8:43 pm EDT | Flagship Ventures Fund IV General Partner LLC +310% Owner | 281,250 | $16.00 | $4,500,000 | 18,233,403 | +1.57% | plan? |
| May 11, 2018 CForm 4 → | May 15, 8:43 pm EDT | Flagship Ventures Fund IV General Partner LLC +310% Owner | 14,622,143 | — | — | 17,952,153 | — | plan? |
| May 11, 2018 PForm 4 → | May 15, 8:41 pm EDT | Flagship Ventures Fund V General Partner LLC +910% Owner | 281,250 | $16.00 | $4,500,000 | 18,233,403 | +1.57% | plan? |
| May 11, 2018 CForm 4 → | May 15, 8:41 pm EDT | Flagship Ventures Fund V General Partner LLC +910% Owner | 14,622,143 | — | — | 17,952,153 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2019 AForm 4 → | Jan 16, 8:57 am EST | Mark BodmerCSO, President of R&D | 100,000 | — | — | 100,000 | — | |
| Jan 14, 2019 AForm 4 → | Jan 16, 8:54 am EST | Simba GillPresident & CEO, Director | 220,000 | — | — | 220,000 | — | |
| Jan 14, 2019 AForm 4 → | Jan 16, 8:48 am EST | Jonathan PooleCFO | 100,000 | — | — | 100,000 | — | |
| Oct 31, 2018 AForm 4 → | Nov 1, 4:41 pm EDT | Daniel CharGeneral Counsel | 100,000 | — | — | 100,000 | — | |
| May 11, 2018 CForm 4 → | May 21, 4:48 pm EDT | Alexandria Venture Investments, LLC10% Owner | 2,424,734 | — | — | 0 | — | late |
| May 11, 2018 CForm 4 → | May 15, 8:43 pm EDT | Flagship Ventures Fund IV General Partner LLC +310% Owner | 59,643,740 | — | — | 0 | — | |
| May 11, 2018 CForm 4 → | May 15, 8:41 pm EDT | Flagship Ventures Fund V General Partner LLC +910% Owner | 59,643,740 | — | — | 0 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:06 pm EDT | Jonathan PooleCFO | 71,497 | — | — | 71,497 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:06 pm EDT | Simba GillPresident & CEO, Director | 145,869 | — | — | 145,869 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:05 pm EDT | Duncan McHaleChief Medical Officer | 79,052 | — | — | 79,052 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:04 pm EDT | Mark BodmerSee Remarks | 55,437 | — | — | 55,437 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:04 pm EDT | Nancy A SimonianDirector | 31,380 | — | — | 31,380 | — |